首页> 外文期刊>American Journal of Epidemiology >Results of Multivariable Logistic Regression, Propensity Matching, Propensity Adjustment, and Propensity-based Weighting under Conditions of Nonuniform Effect
【24h】

Results of Multivariable Logistic Regression, Propensity Matching, Propensity Adjustment, and Propensity-based Weighting under Conditions of Nonuniform Effect

机译:非均匀效应条件下多元Logistic回归,倾向匹配,倾向调整和基于倾向的加权结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Observational studies often provide the only available information about treatment effects. Control of confounding, however, remains challenging. The authors compared five methods for evaluating the effect of tissue plasminogen activator on death among 6,269 ischemic stroke patients registered in a German stroke registry: multivariable logistic regression, propensity score–matched analysis, regression adjustment with the propensity score, and two propensity score–based weighted methods—one estimating the treatment effect in the entire study population (inverse-probability-of-treatment weights), another in the treated population (standardized-mortality-ratio weights). Between 2000 and 2001, 212 patients received tissue plasminogen activator. The crude odds ratio between tissue plasminogen activator and death was 3.35 (95% confidence interval: 2.28, 4.91). The adjusted odds ratio depended strongly on the adjustment method, ranging from 1.11 (95% confidence interval: 0.67, 1.84) for the standardized-mortality-ratio weighted to 10.77 (95% confidence interval: 2.47, 47.04) for the inverse-probability-of-treatment-weighted analysis. For treated patients with a low propensity score, risks of dying were high. Exclusion of patients with a propensity score of <5% yielded comparable odds ratios of approximately 1 for all methods. High levels of nonuniform treatment effect render summary estimates very sensitive to the weighting system explicit or implicit in an adjustment technique. Researchers need to be clear about the population for which an overall treatment estimate is most suitable.
机译:观察性研究通常提供有关治疗效果的唯一可用信息。但是,混杂的控制仍然具有挑战性。作者比较了在德国中风登记处登记的6269名缺血性中风患者中评估组织纤溶酶原激活物对死亡影响的五种方法:多变量logistic回归,倾向得分匹配分析,以倾向得分进行回归调整,以及两种基于倾向得分的方法加权方法-一种用于估计整个研究人群的治疗效果(治疗的概率反比),另一种用于估计治疗人群的治疗效果(标准化死亡率-比重)。在2000年至2001年之间,有212名患者接受了组织纤溶酶原激活剂。组织纤溶酶原激活物与死亡之间的比值比为3.35(95%置信区间:2.28、4.91)。调整后的优势比很大程度上取决于调整方法,范围从标准化死亡率的加权系数1.11(95%置信区间:0.67、1.84)到逆概率-10.77(95%置信区间:2.47、47.04)。治疗加权分析。对于倾向评分低的接受治疗的患者,死亡的风险较高。对于所有方法,排除倾向得分<5%的患者可得到的可比优势比约为1。高水平的非均匀处理效果使摘要估计对调整技术中显式或隐式的加权系统非常敏感。研究人员需要明确总体治疗估计最适合的人群。

著录项

  • 来源
    《American Journal of Epidemiology》 |2006年第3期|262-270|共9页
  • 作者单位

    Division of Preventive Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA;

    Division of Aging Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA;

    Department of Epidemiology Harvard School of Public Health Boston MA;

    i3 Drug Safety Auburndale MA;

    Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA;

    Department of Biostatistics Harvard School of Public Health Boston MA;

    Massachusetts Veterans Epidemiology Research and Information Center Boston VA Healthcare System Boston MA;

    Institute of Epidemiology and Social Medicine University of Muenster Muenster Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号